Literature DB >> 33351798

miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy.

Laurie Laugier1, Ludmila Rodrigues Pinto Ferreira2,3,4, Frederico Moraes Ferreira2,3,4, Sandrine Cabantous1, Amanda Farage Frade2,3,4, Joao Paulo Nunes2,3,4, Rafael Almeida Ribeiro2,3,4, Pauline Brochet5, Priscila Camillo Teixeira2,3,4, Ronaldo Honorato Barros Santos6, Edimar A Bocchi6, Fernando Bacal6, Darlan da Silva Cândido2,3,4, Vanessa Escolano Maso7, Helder I Nakaya7,8, Jorge Kalil2,3,4, Edecio Cunha-Neto2,3,4, Christophe Chevillard5.   

Abstract

Chronic Chagas disease cardiomyopathy (CCC), an especially aggressive inflammatory dilated cardiomyopathy caused by lifelong infection with the protozoan Trypanosoma cruzi, is a major cause of cardiomyopathy in Latin America. Although chronic myocarditis may play a major pathogenetic role, little is known about the molecular mechanisms responsible for its severity. The aim of this study is to study the genes and microRNAs expression in tissues and their connections in regards to the pathobiological processes. To do so, we integrated for the first time global microRNA and mRNA expression profiling from myocardial tissue of CCC patients employing pathways and network analyses. We observed an enrichment in biological processes and pathways associated with the immune response and metabolism. IFNγ, TNF and NFkB were the top upstream regulators. The intersections between differentially expressed microRNAs and differentially expressed target mRNAs showed an enrichment in biological processes such as Inflammation, inflammation, Th1/IFN-γ-inducible genes, fibrosis, hypertrophy, and mitochondrial/oxidative stress/antioxidant response. MicroRNAs also played a role in the regulation of gene expression involved in the key cardiomyopathy-related processes fibrosis, hypertrophy, myocarditis and arrhythmia. Significantly, a discrete number of differentially expressed microRNAs targeted a high number of differentially expressed mRNAs (>20) in multiple processes. Our results suggest that miRNAs orchestrate expression of multiple genes in the major pathophysiological processes in CCC heart tissue. This may have a bearing on pathogenesis, biomarkers and therapy.

Entities:  

Year:  2020        PMID: 33351798      PMCID: PMC7787679          DOI: 10.1371/journal.pntd.0008889

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  73 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.

Authors:  Katrina L Ellis; Vicky A Cameron; Richard W Troughton; Chris M Frampton; Leigh J Ellmers; A Mark Richards
Journal:  Eur J Heart Fail       Date:  2013-05-21       Impact factor: 15.534

3.  Chronic inflammatory cardiomyopathy of interferon γ-overexpressing transgenic mice is mediated by tumor necrosis factor-α.

Authors:  Michael Torzewski; Philip Wenzel; Hartmut Kleinert; Christoph Becker; Jasmin El-Masri; Elena Wiese; Moritz Brandt; Andrea Pautz; Laura Twardowski; Edgar Schmitt; Thomas Münzel; Kurt Reifenberg
Journal:  Am J Pathol       Date:  2011-11-01       Impact factor: 4.307

4.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 5.  microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.

Authors:  Bingqian Yan; Huijing Wang; Yao Tan; Wei Fu
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

Review 6.  Could interferon-gamma be a therapeutic target for treating heart failure?

Authors:  Scott P Levick; Paul H Goldspink
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease.

Authors:  Amanda Farage Frade; Laurie Laugier; Ludmila Rodrigues Pinto Ferreira; Monique Andrade Baron; Luiz Alberto Benvenuti; Priscila Camillo Teixeira; Isabela Cunha Navarro; Sandrine Cabantous; Frederico Moraes Ferreira; Darlan da Silva Cândido; Fabio Antônio Gaiotto; Fernando Bacal; Pablo Pomerantzeff; Ronaldo Honorato Barros Santos; Jorge Kalil; Edecio Cunha-Neto; Christophe Chevillard
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

8.  Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro.

Authors:  H Luss; S C Watkins; P D Freeswick; A K Imro; A K Nussler; T R Billiar; R L Simmons; P J del Nido; F X McGowan
Journal:  J Mol Cell Cardiol       Date:  1995-09       Impact factor: 5.000

9.  Predictors of outcome in patients with suspected myocarditis.

Authors:  Ingrid Kindermann; Michael Kindermann; Reinhard Kandolf; Karin Klingel; Burkhard Bültmann; Thomas Müller; Angelika Lindinger; Michael Böhm
Journal:  Circulation       Date:  2008-07-21       Impact factor: 29.690

10.  MiR-103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts.

Authors:  Hanping Qi; Jing Ren; Mingyao E; Qianhui Zhang; Yonggang Cao; Lina Ba; Chao Song; Pilong Shi; Bowen Fu; Hongli Sun
Journal:  J Cell Mol Med       Date:  2019-01-03       Impact factor: 5.310

View more
  10 in total

Review 1.  The role of non-coding RNAs in myocarditis: a narrative review.

Authors:  Wenhu Liu; Jing Hu; Shuai Lu; Zhaohui Wang
Journal:  Ann Transl Med       Date:  2022-09

2.  Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease.

Authors:  Edecio Cunha-Neto; Christophe Chevillard; Maryem Ouarhache; Sandrine Marquet; Amanda Farage Frade; Ariela Mota Ferreira; Barbara Ianni; Rafael Ribeiro Almeida; Joao Paulo Silva Nunes; Ludmila Rodrigues Pinto Ferreira; Vagner Oliveira-Carvalho Rigaud; Darlan Cândido; Charles Mady; Ricardo Costa Fernandes Zaniratto; Paula Buck; Magali Torres; Frederic Gallardo; Pauline Andrieux; Sergio Bydlowsky; Debora Levy; Laurent Abel; Clareci Silva Cardoso; Omar Ribeiro Santos-Junior; Lea Campos Oliveira; Claudia Di Lorenzo Oliveira; Maria Do Carmo Nunes; Aurelie Cobat; Jorge Kalil; Antonio Luiz Ribeiro; Ester Cerdeira Sabino
Journal:  J Clin Immunol       Date:  2021-03-03       Impact factor: 8.542

Review 3.  Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease.

Authors:  Luíza Dantas-Pereira; Rubem Menna-Barreto; Joseli Lannes-Vieira
Journal:  Front Cell Dev Biol       Date:  2021-12-20

4.  Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts.

Authors:  Priscila Silva Grijó Farani; Beatriz Iandra Silva Ferreira; Daniel Gibaldi; Joseli Lannes-Vieira; Otacilio Cruz Moreira
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

5.  Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.

Authors:  Jiahe Wu; Jianlei Cao; Xiaorong Hu; Yongzhen Fan; Chenze Li
Journal:  BMC Med Genomics       Date:  2021-11-29       Impact factor: 3.063

6.  Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients.

Authors:  Priscila Camillo Teixeira; Axel Ducret; Hanno Langen; Everson Nogoceke; Ronaldo Honorato Barros Santos; João Paulo Silva Nunes; Luiz Benvenuti; Debora Levy; Sergio Paulo Bydlowski; Edimar Alcides Bocchi; Andréia Kuramoto Takara; Alfredo Inácio Fiorelli; Noedir Antonio Stolf; Pablo Pomeranzeff; Christophe Chevillard; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

7.  Co-Exposure of Cardiomyocytes to IFN-γ and TNF-α Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopathy.

Authors:  João Paulo Silva Nunes; Pauline Andrieux; Pauline Brochet; Rafael Ribeiro Almeida; Eduardo Kitano; André Kenji Honda; Leo Kei Iwai; Débora Andrade-Silva; David Goudenège; Karla Deysiree Alcântara Silva; Raquel de Souza Vieira; Débora Levy; Sergio Paulo Bydlowski; Frédéric Gallardo; Magali Torres; Edimar Alcides Bocchi; Miguel Mano; Ronaldo Honorato Barros Santos; Fernando Bacal; Pablo Pomerantzeff; Francisco Rafael Martins Laurindo; Priscila Camillo Teixeira; Helder I Nakaya; Jorge Kalil; Vincent Procaccio; Christophe Chevillard; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

8.  Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy.

Authors:  Pauline Brochet; Barbara Maria Ianni; Laurie Laugier; Amanda Farage Frade; João Paulo Silva Nunes; Priscila Camillo Teixeira; Charles Mady; Ludmila Rodrigues Pinto Ferreira; Quentin Ferré; Ronaldo Honorato Barros Santos; Andreia Kuramoto; Sandrine Cabantous; Samuel Steffen; Antonio Noedir Stolf; Pablo Pomerantzeff; Alfredo Inacio Fiorelli; Edimar Alcides Bocchi; Cristina Wide Pissetti; Bruno Saba; Darlan da Silva Cândido; Fabrício C Dias; Marcelo Ferraz Sampaio; Fabio Antônio Gaiotto; José Antonio Marin-Neto; Abílio Fragata; Ricardo Costa Fernandes Zaniratto; Sergio Siqueira; Giselle De Lima Peixoto; Vagner Oliveira-Carvalho Rigaud; Fernando Bacal; Paula Buck; Rafael Ribeiro Almeida; Hui Tzu Lin-Wang; André Schmidt; Martino Martinelli; Mario Hiroyuki Hirata; Eduardo Antonio Donadi; Alexandre Costa Pereira; Virmondes Rodrigues Junior; Denis Puthier; Jorge Kalil; Lionel Spinelli; Edecio Cunha-Neto; Christophe Chevillard
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

9.  Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy.

Authors:  Sergio Alejandro Gómez-Ochoa; Paula Katherine Bautista-Niño; Lyda Z Rojas; Lukas Hunziker; Taulant Muka; Luis E Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2022-08-08       Impact factor: 6.073

10.  Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach.

Authors:  Joseli Lannes-Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-23       Impact factor: 2.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.